Stanmore Coal share price lifts 2.3% on strong half year results

The Stanmore Coal Limited (ASX: SMR) share price closed 2.3% higher today with the release of the company's strong interim results which succeeded in meeting guidance.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Stanmore Coal Limited (ASX: SMR) share price closed 2.3% higher today with the release of the company's half-year results for the period ending 31 December 2018.

The Stanmore share price now sits at $1.10, decidedly higher than the $0.95 per share offer made by Golden Investments which expired on the 23 January.

a woman

Financial performance

The company showed record financial performance for the half year, attributable to "strong coking coal prices, increased volumes, improved sales mix between coking coal and thermal coal and a continued focus on cost control".

Underlying EBITDA of $41.6 million was in line with guidance and puts Stanmore on track to meet FY19 underlying EBITDA in the range of $140–$155 million.

A summary of Stanmore's other financial results for the half year ending 31 December 2018 is provided below:

  • Profit after tax of $21.3 million (165% growth on the previous corresponding period)
  • Revenue of $148.3 million (79% growth pcp)
  • Gross margin of 48.1% (33.7% in pcp)
  • Interim fully-franked dividend of 3 cents per share

Operating performance

  • The company is on track to meet full-year coal production guidance of 2.15mt, representing a 90% increase on FY18.
  • Record coal production of 978kt (91% growth pcp)
  • Reduction in waste removal costs due to the relocation of operations to the new Isaac Plains East Mine, which has a more favourable strip ratio

The Stanmore Coal share price has climbed 73% higher over the last 12 months, compared to the S&P/ASX 200 index which has risen 4.4%.

Motley Fool contributor Cale Kalinowski has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »